Company newsCVS
Explain this story: Why McKesson Stock Soared More Than 5% Higher Today
McKesson stock gained over 5% after announcing an extension of its long-standing partnership with CVS Health until June 2032. The agreement ensures McKesson will continue distributing medicines to CVS's various pharmacy operations. McKesson also reaffirmed its fiscal year 2027 and long-term earnings guidance, highlighting its strong position in the healthcare distribution market.
OtherYahoo FinanceSector and industry: HealthcareHealthcare PlansTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
McKesson stock gained over 5% after announcing an extension of its long-standing partnership with CVS Health until June 2032. The agreement ensures McKesson will continue distributing medicines to CVS's various pharmacy operations. McKesson also reaffirmed its fiscal year 2027 and long-term earnings guidance, highlighting its strong position in the healthcare distribution market.
Article tone: Neutral This describes the words the journalist used. It is not a prediction, and not advice.
Published Oct 1, 2026, 19:59 ET · on this site +2h 3m